Clinical Trials for Novatim Immune Therapeutics

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Novatim Immune Therapeutics

Clinical Trials (7)

NCT06928363
A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.
PHASE1/PHASE2Not yet recruiting
212 participants
Started: May 1, 2025 · Completed: Dec 15, 2027
1 condition1 sponsor0 locations
NCT06518876
A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome
PHASE1Not yet recruiting
21 participants
Started: Aug 31, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06445803
CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL
PHASE1Recruiting
48 participants
Started: May 31, 2024 · Completed: Dec 31, 2026
4 conditions2 sponsors2 locations
NCT06223646
A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
29 participants
Started: Jan 11, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06175780
Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors
PHASE1Recruiting
189 participants
Started: Dec 28, 2022 · Completed: Dec 28, 2025
2 conditions1 sponsor8 locations
NCT04714827
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
24 participants
Started: Jan 22, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04715217
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma
PHASE1/PHASE2Recruiting
24 participants
Started: Jan 4, 2021 · Completed: Oct 31, 2025
1 condition2 sponsors1 location